| Biologic Therapy |
1 |
1 |
| Stem Cell Research and Therapy |
0 |
0.99 |
| Non-Hodgkin Lymphoma (NHL) |
0 |
0.92 |
| CAR-T |
0 |
0.75 |
| Transplantation |
0 |
0.61 |
| Cell Transplantation |
0 |
0.98 |
| Refractory |
0 |
0.41 |
| T-Lymphocyte |
0 |
0.41 |
| B-Cell Lymphoma |
0 |
0.97 |
| Lymphoma |
0 |
0.31 |
| Genomic Medicine |
0 |
0.95 |
| Gene Therapy |
0 |
0.96 |
| Thrombocytopenia |
0 |
0.12 |
| Chemotherapy |
0 |
0.1 |
| COVID-19 |
0 |
0.09 |
| Neutropenia |
0 |
0.06 |
| Anemia |
0 |
0.05 |
| Antigens |
0 |
0.05 |
| Cancer |
0 |
0.05 |
| Corticosteroids |
0 |
0.05 |
| Cytokines |
0 |
0.05 |
| Food and Drug Administration (FDA) |
0 |
0.05 |
| Hematocrit |
0 |
0.05 |
| Leukopenia |
0 |
0.05 |
| Prescription Drugs |
0 |
0.05 |
| Prognosis |
0 |
0.05 |
| Receptors |
0 |
0.05 |